A. Klinov

发表

Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Pneumonia

Andrés F. Agudelo, M. Levitt, N. Assy, 2022, medRxiv.

Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter randomized trial

X. Nuvials, R. Favory, A. Zoufaly, 2024, Annals of Intensive Care.

Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO2 Requirements

G. Rizzardini, A. Mayo, A. Barczyk, 2024, Microorganisms.